Comparison between OYO IPO and Rodec Pharma IPO.
OYO IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Rodec Pharma IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of OYO IPO is up to ₹0.00 Cr whereas the issue size of the Rodec Pharma IPO is up to ₹0.00 Cr. The final issue price of OYO IPO is and of Rodec Pharma IPO is .
| OYO IPO | Rodec Pharma IPO | |
|---|---|---|
| Face Value | ₹10 per share | |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 56,50,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 56,50,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
OYO IPO opens on , while Rodec Pharma IPO opens on . The closing date of OYO IPO and Rodec Pharma IPO is , and , respectively.
OYO IPO P/E ratio is , as compared to Rodec Pharma IPO P/E ratio of .
| OYO IPO | Rodec Pharma IPO | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Standalone)
| ||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 92.40 | ||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||||||
| ROE | 36.49% | ||||||||||||||||||||||||||||||||||||
| ROCE | 40.94% | ||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.17 | ||||||||||||||||||||||||||||||||||||
| EPS | ₹8.08 | ||||||||||||||||||||||||||||||||||||
| RoNW | 36.49% | ||||||||||||||||||||||||||||||||||||
In the OYO IPO Retail Individual Investors (RII) are offered while in Rodec Pharma IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in OYO IPO and 0 shares in Rodec Pharma IPO.
| OYO IPO | Rodec Pharma IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | |
| Market Maker Reservation | 0 shares | |
| QIB | 0 shares | |
| NII | 0 shares | |
| RII | 0 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 0 shares |
OYO IPO subscribed in total, whereas Rodec Pharma IPO subscribed .
| OYO IPO | Rodec Pharma IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
